Company data
Kymera Therapeutics, Inc. employees and revenue per employee
KYMR · Biotechnology · $8.83B market cap
Kymera Therapeutics, Inc. had 238 employees at the end of fiscal Dec 2025, up 26.6% from a year earlier. Revenue for the year was $39.2M, down 16.7% from a year earlier, or $165K per employee. Revenue fell while headcount grew.
Employees
238
+26.6% YoY
Revenue
$39.2M
-16.7% YoY
Revenue / employee
$165K
Peer median $602K
Rank in industry
32 of 39
Biotechnology
Open roles
26
109 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 238 | $39.2M | $165K | +26.6% | -16.7% |
| Dec 2024 | 188 | $47.1M | $250K | +0.5% | -40.1% |
| Dec 2023 | 187 | $78.6M | $420K | +12.0% | +67.8% |
| Dec 2022 | 167 | $46.8M | $280K | +18.4% | -35.7% |
| Dec 2021 | 141 | $72.8M | $517K | +88.0% | +114.0% |
| Dec 2020 | 75 | $34.0M | $454K | — | — |
Open roles on its job board: 26 (109 per 1,000 staff, against its latest annual headcount), as of 2026-10-07. Tracked since 2026-10-03. No 90 day change yet.
Kymera Therapeutics, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, Inc. | 123 | $87.4M | $710K | Contracting |
| PTGX Protagonist Therapeutics, Inc. | 132 | $46.0M | $349K | Hiring into decline |
| NUVB Nuvation Bio Inc. | 298 | $62.9M | $211K | Efficient growth |
| KYMR Kymera Therapeutics, Inc. | 238 | $39.2M | $165K | Hiring into decline |
| IBRX ImmunityBio, Inc. | 691 | $113M | $164K | Efficient growth |
| CYTK Cytokinetics, Incorporated | 673 | $88.0M | $131K | Efficient growth |
| RLAY Relay Therapeutics, Inc. | 192 | $15.4M | $80K | Leaner |
| PRAX Praxis Precision Medicines, Inc. | 116 | $8.6M | $74K | Efficient growth |
| PGEN Precigen, Inc. | 160 | $9.7M | $61K | Efficient growth |
Questions about Kymera Therapeutics, Inc.
- How many employees does Kymera Therapeutics, Inc. have?
- Kymera Therapeutics, Inc. reported 238 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 26.6% from a year earlier.
- What is Kymera Therapeutics, Inc.'s revenue per employee?
- Kymera Therapeutics, Inc. brought in $39.2M of revenue in fiscal Dec 2025, which is $165K per employee. That ranks 32 of 39 companies we track in Biotechnology, where the median is $602K.
- Is Kymera Therapeutics, Inc. hiring?
- Kymera Therapeutics, Inc.'s public job board listed 26 open roles on October 7, 2026, about 109 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare KYMR with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Kymera Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell KYMR.